Recent studies reveal metformin's varied effects: it may extend lifespan in older women with diabetes by 30 percent, but failed to improve long COVID symptoms when given after infection developed.
Recent research explores outcomes when patients stop GLP-1 medications and finds pharmacist-led interventions can help older adults avoid dangerous low blood sugar episodes.
Scientists in China report reversing Type 2 diabetes in a patient using stem cell therapy, while a separate study finds metformin may help women with diabetes live past 90. Both findings require larger trials.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05751525 |
Impact of Sulphonylureas on Neurodevelopmental Outcomes in KCNJ11-related Intermediate Developmental Delay, Epilepsy and Neonatal Diabetes (iDEND) Syndrome |
RECRUITING | |
| NCT05214573 |
Second-line Therapies for Patients With Type 2 Diabetes and Moderate Cardiovascular Disease Risk |
COMPLETED | |
| NCT05102071 |
Clinical Outcomes and Healthcare Cost and Resource Utilization (HCRU) in Patients With Type 2 Diabetes and Cardiovascular Disease on 2nd Line Empagliflozin Versus 2nd Line Sulfonylureas |
WITHDRAWN | |
| NCT04239586 |
Switching From Insulin to Sulfonylurea in Diabetes Associated With Variants in MODY Genes |
UNKNOWN | PHASE4 |
| NCT04192292 |
Study of Sulphonylurea Synergy With DPP4 Inhibitors |
COMPLETED | NA |
| NCT03983551 |
Comparing the Renal Effect of Dipeptidyl-peptidase 4 Inhibitors and Sulfonylureas |
COMPLETED | PHASE4 |
| NCT03936062 |
Replication of the TECOS Diabetes Trial in Healthcare Claims |
COMPLETED | |
| NCT03936036 |
Replication of the CARMELINA Diabetes Trial in Healthcare Claims |
COMPLETED | |
| NCT03936023 |
Replication of the SAVOR-TIMI Diabetes Trial in Healthcare Claims |
COMPLETED | |
| NCT03921242 |
Comparative Effectiveness of Metformin for Type 2 Diabetes With Chronic Kidney Disease |
COMPLETED |
